Capstan Medical
Capstan Medical Raises $110M Series C | Cardiac Surgical Robotics
Capstan Medical Closes $110M for Surgical Robotics
Capstan Medical, a company creating minimally invasive technologies to treat heart valve disorders, has raised $110 million in Series C funding.
The round was led by Eclipse Ventures with participation from Intuitive Ventures, Meritech Capital, and Gideon Strategic Partners.
Key Highlights
- Total funding to date: $141.4 million
- Advanced surgical robotics for cardiac procedures
- Backed by Intuitive Surgical venture arm
Company Overview
Capstan Medical is developing advanced surgical robotics and instrumentation for minimally invasive cardiac procedures, focusing on heart valve repair and replacement.
Company Info
Investors (3)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started